Cti Biopharma reported $10.21M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Applied Genetic Technologies AGTC:US $ 3.88M 686K
Baxter International BAX:US $ 648M 44M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Cti Biopharma CTIC:US $ 10.21M 2.59M
Cytori Therapeutics CYTX:US $ 1.47M 117K
Eli Lilly And LLY:US $ 1.69B 109.7M
Geron GERN:US $ 7.06M 419K
Mirati Therapeutics MRTX:US $ 29.61M 1.26M
Northwest Biotherapeutics NWBO:US 7.37M 5.51M
Novartis NOVN:VX 3.71B 190M
Novartis NVS:US 3.71B 190M
Seattle Genetics SGEN:US $ 165.13M 5.29M
Sunesis Pharmaceuticals SNSS:US $ 3.87M 31K
Teva Pharmaceutical Industries TEVA:US 832M 16M
YTE INCY:US $ 168.86M 15.06M